SMS PHARMACEUTICALS LTD. - 532815 - Shareholding for the Period Ended June 30, 2021
SMS Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here08-07-2021
08-07-2021
SMS Pharmaceuticals Ltd - 532815 - Closure of Trading Window
This is to inform you that the Trading Window for dealing in securities of the Company by Directors, Promoters, Designated Employees and Specified Connected Persons of the Company and associated of the Company shall remain closed with effect from 1st July, 2021 till conclusion of 48 hours after the declaration of Financial Results of the Company for the quarter ended 30th June, 2021, in terms of code of conduct of the Company. This is for your information and records.30-06-2021
SMS PHARMACEUTICALS LTD. - 532815 - Closure of Trading Window
This is to inform you that the Trading Window for dealing in securities of the Company by Directors, Promoters, Designated Employees and Specified Connected Persons of the Company and associated of the Company shall remain closed with effect from 1st July, 2021 till conclusion of 48 hours after the declaration of Financial Results of the Company for the quarter ended 30th June, 2021, in terms of code of conduct of the Company. This is for your information and records.30-06-2021
SMS Pharmaceuticals Ltd - 532815 - Compliances-Reg.24(A)-Annual Secretarial Compliance
We are herewith submitting the Annual Secretarial Compliance Report issued by CSB Associates, Mr. C.Sudhir Babu, Practicing Company Secretary in compliance with Regulation 24A of SEBI (LODR) Regulations, 2015 for the financial year 2020-21.25-06-2021
SMS PHARMACEUTICALS LTD. - 532815 - Submission Of Half Yearly Disclosure On Related Party Transactions. Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements), Regulations, 2015.
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended 31st March, 2021. This is for your information and Records.24-06-2021
SMS PHARMACEUTICALS LTD. - 532815 - Board recommends Dividend
SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2021, inter alia, has considered and approved the following:- Declaration of Dividend for the year 2020-21 @ Re. 0.30/- (30%) per equity share of Re. 1/- each.28-05-2021
SMS PHARMACEUTICALS LTD. - 532815 - Outcome Of Board Meeting
Outcome of Board meeting held on 28th May, 2021.28-05-2021
SMS Pharmaceuticals Ltd - 532815 - Considering The Dividend For The Financial Year 2020-21
In-furtherance to our Board meeting intimation dated 21st May, 2021 and pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that in the Board Meeting scheduled to be held on Friday, 28th May, 2021, Board shall also consider declaration of dividend for the financial year 2020-21, along with other agenda(s).26-05-2021
SMS Pharmaceuticals Ltd - 532815 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On 28.05.2021
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2021 ,inter alia, to consider and approve NOTICE is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013 that a meeting of the Board of Directors of the Company will be held on the Friday 28th day of May, 2021, at the Registered Office of the Company, inter alia, for the following items: 1. To consider and approve the Audited Standalone and consolidated Quarterly results for the fourth Quarter ended on 31st March, 2021. 2. To consider and approve Standalone and Consolidated Annual Audited Financial Statements for the financial year ended on 31st March, 2021. Please be informed that Insider Trading window of SMS Pharmaceuticals Limited shall remain closed till 30th May, 2021 in view of the above mentioned Board Meeting.21-05-2021
SMS PHARMACEUTICALS LTD. - 532815 - Disclosure Under Large Corporate Criteria
Initial Disclosure by any entity identified as Large Corporate ('LC')30-04-2021